Cyclobenzaprine: Difference between revisions
ClaireLewis (talk | contribs) (Created page with "==Administration== *Type: muscle relaxant *Dosage Forms: *Routes of Administration: Oral *Common Trade Names: Flexeril ==Adult Dosing== *5-10mg PO 1-3 times per day ==Pediatr...") |
|||
| Line 37: | Line 37: | ||
*Half-life: ~18h for immediate release, 32h for extended release | *Half-life: ~18h for immediate release, 32h for extended release | ||
*Metabolism: hepatic | *Metabolism: hepatic | ||
*Excretion: | *Excretion: Urine | ||
==Mechanism of Action== | ==Mechanism of Action== | ||
Revision as of 18:34, 12 October 2017
Administration
- Type: muscle relaxant
- Dosage Forms:
- Routes of Administration: Oral
- Common Trade Names: Flexeril
Adult Dosing
- 5-10mg PO 1-3 times per day
Pediatric Dosing
Special Populations
- Pregnancy Rating: B
- Lactation risk: infant risk cannot be ruled out
Renal Dosing
- Adult:
- Pediatric:
Hepatic Dosing
- Adult: Titrate slowly
- Pediatric:
Contraindications
- Allergy to class/drug
- MAOI use, concomitantly or within 14 days
- Heart block or other serious arrhythmias, CHF
Adverse Reactions
Serious
- Neuroleptic malignant syndrome
- Serotonin syndrome
- Stroke
- Dysrhythmias, heart block
- Bone marrow depression
- Hepatitis
Common
- Somnolence, dizziness
- Nausea, constipation
Pharmacology
- Half-life: ~18h for immediate release, 32h for extended release
- Metabolism: hepatic
- Excretion: Urine
Mechanism of Action
- Acts on CNS to reduce tonic somatic motor activity